Author:
Naziri Zahra,Rahimlou Mehran,Rezaei Mehdi,Tabrizi Reza,Nasr Mohammadsadegh,Motazedian Mohammadreza,Kardeh Sina
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. Hahla MS, Saeed Y, Razieh H. Comparison of risk factors & clinical and angiographic characterization of STEMI in young adults with older patients. Research journal of pharmaceutical biological and chemical sciences; 2016;7(6):2013–6.
2. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010;362(23):2155–65.
3. Bishu KG, Lekoubou A, Kirkland E, Schumann SO, Schreiner A, Heincelman M, et al. Estimating the economic burden of acute myocardial infarction in the US: 12 year national data. Am J Med Sci. 2020;359(5):257–65.
4. Vanherle L, Lidington D, Uhl FE, Steiner S, Vassallo S, Skoug C, et al. Restoring myocardial infarction-induced long-term memory impairment by targeting the cystic fibrosis transmembrane regulator. EBioMedicine. 2022;86:104384.
5. Zhuang L, Zong X, Yang Q, Fan Q, Tao R. Interleukin-34-NF-κB signaling aggravates myocardial ischemic/reperfusion injury by facilitating macrophage recruitment and polarization. EBioMedicine. 2023;95:104744.